Clinical Trial Update: Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose ethosuximide for efficacy and tolerability in peripheral neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathic Pain

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Peripheral Neuropathic Pain | Phase 2 | Status: UNKNOWN